Aer Therapeutics, Inc.
Aer Therapeutics is a clinical stage biopharmaceutical company developing AER-01 (fexlamose) to treat serious muco-obstructive respiratory diseases such as COPD, asthma, Cystic Fibrosis and bronchiectasis
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
